Bavarian Nordic A/S has signed a new alliance with the U.S. Department of Defense (DoD) for the development of a prophylactic vaccine against the equine encephalitis virus-a rare, but potentially deadly mosquito-borne illness. With funding from the DoD, Bavarian Nordic will use its proprietary MVA-BN platform to develop a vaccine against various strains of the virus, for which there is currently no preventative vaccine treatment available. An MVA-BN-based candidate vaccine targeting three sep...